Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
March 2016 - 59 products
IP
CI
CM
Metoprolol-Mepha 25 mg
Depotabs
30 Tablet(s)
2.13
11.55
10 %
Metoprololi Tartras 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 25 mg
Depotabs
100
6.21
16.00
10 %
Metoprololi Tartras 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 50 mg
30 Tablet(s)
3.68
13.25
10 %
Delayed release tablets: Metoprololi Tartras 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 50 mg
100
10.55
27.90
10 %
Delayed release tablets: Metoprololi Tartras 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 100 mg
30 Tablet(s)
5.83
15.60
10 %
Delayed release tablets: Metoprololi Tartras 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 100 mg
100
16.84
34.75
10 %
Delayed release tablets: Metoprololi Tartras 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 200 mg
30 Tablet(s)
7.10
16.95
10 %
Delayed release tablets: Metoprololi Tartras 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Metoprolol-Mepha 200 mg
100
21.18
39.45
10 %
Delayed release tablets: Metoprololi Tartras 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 50mg
60 Tablet(s)
30.51
49.60
10 %
Delayed release tablets: Quetiapinum 50 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 150mg
60 Tablet(s)
58.38
79.90
10 %
Delayed release tablets: Quetiapinum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 150mg
100
97.30
122.25
10 %
Delayed release tablets: Quetiapinum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 200mg
60 Tablet(s)
72.22
94.95
10 %
Delayed release tablets: Quetiapinum 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 200mg
100
118.57
145.35
10 %
Delayed release tablets: Quetiapinum 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 300mg
60 Tablet(s)
102.06
127.40
10 %
Delayed release tablets: Quetiapinum 300 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 300mg
100
167.35
198.40
10 %
Delayed release tablets: Quetiapinum 300 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 400mg
60 Tablet(s)
141.66
170.50
10 %
Delayed release tablets: Quetiapinum 400 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Sandoz 400mg
100
236.10
273.20
10 %
Delayed release tablets: Quetiapinum 400 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Cinacalcet-Mepha 30 mg
28
128.50
156.15
10 %
Coated tablets: Cinacalcetum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Cinacalcet-Mepha 60 mg
28
225.40
261.55
10 %
Coated tablets: Cinacalcetum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Cinacalcet-Mepha 90 mg
28
318.50
362.80
10 %
Coated tablets: Cinacalcetum 90 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Exemestan Devatis 25 mg
30
63.00
85.05
10 %
Coated tablets: Exemestanum 25 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Exemestan Devatis 25 mg
100
207.68
242.35
10 %
Coated tablets: Exemestanum 25 mg
Devatis AG
B / SL / SG
FB
G
IP
Fluorouracil Labatec 250
mg/5 ml
2.97
12.45
10 %
Solution injectable/pour perfusion: Fluorouracilum 250mg / 5ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Fluorouracil Labatec 500
mg/10 ml
4.34
13.95
10 %
Solution injectable/pour perfusion: Fluorouracilum 500mg / 10ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Fluorouracil Labatec 1000
mg/20 ml
6.73
16.55
10 %
Solution injectable/pour perfusion: Fluorouracilum 1000mg / 20ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Fluorouracil Labatec 5000
mg/100 ml
26.91
45.70
10 %
Solution injectable/pour perfusion: Fluorouracilum 5000mg / 100ml
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
CI
Cortiment MMX 9mg
30
86.47
110.45
10 %
Delayed release tablets: Budesonidum 9 mg
Ferring AG
B / SL
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
30 Tablet(s)
2.10
11.50
10 %
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B / SL
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
60 Tablet(s)
4.20
13.80
10 %
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B / SL
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
100
5.55
15.25
10 %
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B / SL
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
100
5.55
15.25
10 %
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B / SL
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
120 Tablet(s)
7.12
17.00
10 %
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B / SL
FB
G
IP
Abilify Maintena 400 mg
Fertigspritze(n)
271.72
311.95
10 %
Depot-Injektionssuspension in einer Fertigspritze: Aripiprazolum 400 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
L
IP
CI
Orencia 125 mg/1 ml
4
945.54
1044.75
10 %
Injektionslösung zur subkutanen Anwendung (Fertigpen): Abataceptum 125 mg/ml
Bristol-Myers Squibb SA
B / SL
FB
G
IP
CI
CM
Metoprolol-Mepha 25 mg
Depotabs
50 Tablet(s)
PR
PR
k.A.
Metoprololi Tartras 25 mg
Mepha Pharma AG
B
FB
G
IP
CI
CM
Flector Plus Tissugel
2
PR
PR
k.A.
Patch: 2 Active Agents
IBSA Institut
Biochimique SA
D
FB
G
IP
CI
CM
Flector Plus Tissugel
10
PR
PR
k.A.
Patch: 2 Active Agents
IBSA Institut
Biochimique SA
D
FB
G
IP
CI
CM
Metoprolol-Mepha 50 mg
50 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Metoprololi Tartras 50 mg
Mepha Pharma AG
B
FB
G
IP
CI
CM
Metoprolol-Mepha 100 mg
50 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Metoprololi Tartras 100 mg
Mepha Pharma AG
B
FB
G
IP
CI
CM
Metoprolol-Mepha 200 mg
50 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Metoprololi Tartras 200 mg
Mepha Pharma AG
B
FB
G
IP
CI
Quetiapin XR Sandoz 50mg
60
PR
PR
k.A.
Delayed release tablets: Quetiapinum 50 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Quetiapin XR Sandoz 150mg
60 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Quetiapinum 150 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Quetiapin XR Sandoz 200mg
60 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Quetiapinum 200 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Quetiapin XR Sandoz 300mg
60 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Quetiapinum 300 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Quetiapin XR Sandoz 400mg
60 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Quetiapinum 400 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
ASS Cardio Spirig HC 100 mg
1000
PR
PR
k.A.
Coated tablets: Acidum Acetylsalicylicum 100 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Levomin 20
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
● 
B / LPPV
FB
G
IP
CI
Levomin 20
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B
FB
G
IP
CI
Levomin 20
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Levomin 20
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B
FB
G
IP
CI
Levomin 20
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Levomin 20
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B
FB
G
IP
CI
Ph
Bronchostop Duo
Hustensaft
120 ml
PR
PR
k.A.
Solution (oral): 2 Active Agents
Hänseler AG
D
FB
G
IP
CI
Ph
Bronchostop Duo
Hustensaft
200 ml
PR
PR
k.A.
Solution (oral): 2 Active Agents
Hänseler AG
D
FB
G
IP
CI
Viferol D3 100'000 UI / ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 100000 UI/ml
OM Pharma Suisse SA
B
FB
G
CI
Ph
Sidroga Gallen- und
Lebertee N
20 x 2 g
PR
PR
k.A.
Arzneitee: 6 Active Agents
Uriach Switzerland AG
E
FB
G
IP
Abilify Maintena 300 mg
Fertigspritze(n)
PR
PR
k.A.
Depot-Injektionssuspension in einer Fertigspritze: 2 Active Agents
Lundbeck (Schweiz) AG
B
FB
G
IP
PP
Zerbaxa 1.5 g
10
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
MSD Merck Sharp &
Dohme AG
A
FB
G
IP
CI
Nailcure Sandoz 50mg/ml
2.5 ml
PR
PR
k.A.
wirkstoffhaltiger Nagellack: Amorolfinum 50 mg/ml
Sandoz
Pharmaceuticals AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home